可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Hara M, Ono K, Hwang MW, et al. Evidence for a role of mast cells in the evolution to congestive heart failure [J]. J Exp Med, 2002, 195:375-381.
[2] Matsumoto T, Wada A, Tsutamoto T, et al. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure[J]. Circulation, 2003, 107:2555-2558.
[3] 王斌,赵连友,郑强荪,等. 单核细胞趋化蛋白1对高血压心肌纤维化的作用及其与转化生长因子β的关系[J]. 心脏杂志, 2004, 16(5):417-420.
[4] Nakajima M, Naya N. Development of a chymase inhibitor: pharmacological characterization of a chymase inhibitor in inflamed tissue remodeling and fibrosis [J]. Jpn J Pharmacol, 2002, 90(3):206-209.
[5] Tani K, Ogushi F, Kido H, et al. Chymase is a potent chemoattractant for human monocytes and neutrophils [J]. J Leukoc Biol, 2000, 67(4): 585-589.
[6] Kofford MW, Schwartz LB, Schechter NM, et al. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxylterminal propeptide [J]. J Biol Chem, 1997, 272(11):7127-7131.
[7] Shiota N, Jin D, Takai S, et al. Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension [J]. FEBS Lett, 1997, 406(3):301-304.
[8] 苏兴利,朱伟军. 心肌成纤维细胞在血管紧张素Ⅱ致心脏间质纤维化中的作用[J]. 心脏杂志, 2003,15(2): 163-164.
[9] Takai S, Miyazaki M. A novel therapeutic strategy against vascular disorders with chymase inhibitor [J]. Curr Vasc Pharmacol, 2003, 1(2):217-224.